Thus, several pathways are involved in 13q-H patients (Table 2 and Table S3), BCR signaling, NFkB signaling and antiapoptotic pathways being of special interest in CLL. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.